Frankfurt - Delayed Quote EUR
Paradigm Biopharmaceuticals Limited (P86.F)
0.1690
+0.0160
+(10.46%)
At close: 3:29:01 PM GMT+2
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
65.8000
65.8000
46.7600
79.2240
20.5500
Cost of Revenue
8.9880
8.9880
18.8270
143.7510
99.1380
Gross Profit
56.8120
56.8120
27.9330
-64.5270
-78.5880
Operating Expense
65,249.9300
65,249.9300
60,066.4400
47,925.9990
43,312.0300
Operating Income
-65,193.1180
-65,193.1180
-60,038.5070
-47,990.5260
-43,390.6180
Net Non Operating Interest Income Expense
392.6440
392.6440
1,386.1610
23.1110
171.4040
Other Income Expense
6,000.5500
6,000.5500
6,742.3330
8,656.8620
8,711.9710
Pretax Income
-58,653.1880
-58,653.1880
-51,910.0130
-39,249.5840
-34,297.1840
Net Income Common Stockholders
-58,653.1880
-58,653.1880
-51,910.0130
-39,249.5840
-34,297.1840
Basic EPS
-0.20
-0.20
-0.18
-0.16
-0.16
Diluted EPS
-0.20
-0.20
-0.18
-0.16
-0.16
Basic Average Shares
293,283.5170
293,283.5170
289,678.3530
240,964.3990
212,192.2780
Diluted Average Shares
293,283.5170
293,283.5170
289,678.3530
240,964.3990
212,192.2780
Net Income from Continuing & Discontinued Operation
-58,653.1880
-58,653.1880
-51,910.0130
-39,249.5840
-34,297.1840
Normalized Income
-58,653.1880
-58,653.1880
-51,910.0130
-39,249.5840
-34,297.1840
Interest Income
407.0140
407.0140
1,402.5770
51.7440
209.1260
Interest Expense
14.3700
14.3700
16.4160
28.6330
37.7220
Net Interest Income
392.6440
392.6440
1,386.1610
23.1110
171.4040
EBIT
-58,638.8180
-58,638.8180
-51,893.5970
-39,220.9510
-34,259.4620
EBITDA
-58,492.0820
-58,492.0820
-51,893.5970
-39,159.9820
-34,049.4030
Reconciled Cost of Revenue
8.9880
8.9880
18.8270
143.7510
99.1380
Reconciled Depreciation
146.7360
146.7360
--
60.9690
210.0590
Net Income from Continuing Operation Net Minority Interest
-58,653.1880
-58,653.1880
-51,910.0130
-39,249.5840
-34,297.1840
Normalized EBITDA
-58,492.0820
-58,492.0820
-51,893.5970
-39,159.9820
-34,049.4030
6/30/2021 - 6/26/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NDTP NDT Pharmaceuticals Inc.
0.0905
0.00%
NBCO Neon Bloom, Inc.
0.0121
-5.47%
YECO EV Biologics, Inc.
0.0870
0.00%
STMM Stemcell Holdings, Inc.
0.0600
0.00%
TGRP TRON Group Inc.
0.0300
0.00%
PKTX ProtoKinetix, Incorporated
0.0100
+14.94%
MRZM Marizyme, Inc.
0.0003
0.00%
INTI Inhibitor Therapeutics, Inc.
0.0500
0.00%
SXTPW 60 Degrees Pharmaceuticals, Inc.
0.0570
+3.45%
EMMA Emmaus Life Sciences, Inc.
0.0165
0.00%